Drawing for ARDANA

USPTO serial 76589201

ARDANA

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
HOLTZ, ALLISON
Law office
TMO LAW OFFICE 111 - EXAMINING ATTORNEY ASSIGNED

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with ARDANA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Mark H. Tidman

MARK H TIDMAN ARENT FOX KINTNER PLOTKIN1050 CONNECTICUT AVE NWWASHINGTON, DC 20036UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005PHARMACEUTICAL PREPARATIONS AND PRODUCTS, NAMELY, PREGNANCY TESTS; SANITARY PREPARATIONS AND PRODUCTS, NAMELY, TAMPONS, SANITARY PADS, AND SANITARY NAPKINS; DIETETIC SUBSTANCES FOR MEDICAL USE, NAMELY, DIETARY SUPPLEMENTS AND FOOD FOR MEDICALLY RESTRICTED DIETS; DIAGNOSTIC KITS CONSISTING PRIMARILY OF MEDICAL REAGENTS; DIAGNOSTIC PREPARATIONS FOR MEDICAL USE; DIAGNOSTIC PREPARATIONS FOR MEDICAL USE FOR INCLUSION IN DIAGNOSTIC KITS INCLUDING FOR INCLUSION IN DIAGNOSTIC KITS FOR REPRODUCTIVE HEALTH USES, SEMEN ANALYSIS KITS, KITS TO TEST SPERM FERTILISATION CAPABILITY, HORMONE LEVEL ANALYSIS KITS, KITS FOR TESTING THE PRESENCE AND LEVEL OF LUTENEISING HORMONE (LH), FOLLICLE STIMULATING HORMONE (FSH), BETA-OESTRADIOL, PROLACTIN, PROGESTERONE, HUMAN CHORIONIC GONADOTROPHIN (HCG) AND TESTOSTERONE, KITS TO DETECT GENITAL INFECTIONS, KITS TO DETECT GENITAL INFECTIONS, KITS TO TEST FOR ANTIBODIES TO VARIOUS ORGANISMS, KITS TO DETECT MARKERS OF PRE-TERM-LABOUR, PREGNANCY COMPLICATIONS, MISCARRIAGE AND IMPLANTATION FAILURE, KITS TO DETECT ANTIPHOSPHOLIPIDS, PROTEIN S DEFICIENCY, LUPUS ANTI-COAGULANT AND FACTOR V LEIDEN MUTATION, KITS TO DETECT MARKERS OF FEMALE FERTILITY, KITS TO DETECT DAZL HETROZYGOUS MUTATION AND ASSOCIATED BIOCHEMICAL MARKERS SUCH AS TESTOSTERONE; DIAGNOSTIC PREPARATIONS FOR MEDICAL PURPOSES; CHEMICAL PREPARATIONS FOR THE DIAGNOSIS OF PREGNANCY; CHEMICAL PREPARATIONS FOR MEDICAL DIAGNOSES; DIAGNOSTIC PREPARATIONS AND REAGENTS FOR MEDICAL USE FOR SALE IN KIT FORM; BUT NOT INCLUDING PHARMACEUTICAL PREPARATIONS FOR TREATING DANDRUFFACTIVE—
010DIAGNOSTIC KITS CONSISTING PRIMARILY OF DIPSTICKS TN THE NATURE OF URINE TEST STRIPS, LITMUS PAPER, TEST-TUBES, PIPETTES, STYLETS FOR DRAWING BLOOD SAMPLES, PLASTIC CONTAINERS, SLIDES, SYRINGES, NEEDLES, SPATULAS AND NON-INVASIVE DEVICES, AND MEDICAL DIAGNOSTIC REAGENTS AND PREPARATIONS FOR OBTAINING AND TESTING BIOLOGICAL SAMPLES FOR REPRODUCTIVE HEALTH USES, SEMEN ANALYSIS, TESTING SPERM FERTILIZATION CAPABILITY, HORMONE LEVEL ANALYSIS FOR TESTING THE PRESENCE AND LEVEL OF LUTENEISING HORMONE (LH), FOLLICLE STIMULATING HORMONE (FSH), BETA-QESTRADIOL, PROLACTIN, PROGESTERONE, HUMAN CHORIONICUONADOTROPHIN (HCG) AND TESTOSTERONE, TO DETECT GENITAL INFECTIONS, TO TEST FOR ANTIBODIES TO VARIOUS ORGANISMS, TO DETECT MARKERS OF PRE-TERM LABOR, PREGNANCY COMPLICATIONS, MISCARRIAGE AND IMPLANTATION FAILURE, TO DETECT ANTIPHOSPHOLIPIDS, PROTEINS DEFICIENCY, LUPUS ANTI-COAGULANT AND FACTOR V LEIDEN MUTATION, TO DETECT MARKERS OF FEMALE FERTILITY, TO DETECT DAZL HETEROZYGOUS MUTATION AND ASSOCIATED BIOCHEMICAL MARKERS SUCH AS TESTOSTERONE FOR THE ANALYSIS OF DNA, RNA FOR THE DETECTION OF DISEASE OR PREDISPOSITION ASSOCIATED WITH REPRODUCTION, FOR THE ANALYSIS OF PROTEIN OR OTHER BIOCHEMICAL MARKERS OF DISEASE OR PREDISPOSITION OF DISEASE, TO DETECT BIOCHEMICAL MARKERS WHICH INDICATE DISEASE OR PREDISPOSITION TO DISEASE; SURGICAL AND MEDICAL APPARATUS, NAMELY, DIPSTICKS IN THE NATURE OF URINE TEST STRIPS, STYLETS FOR DRAWING BLOOD SAMPLES, HYPODERMIC SYRINGES, HYPODERMIC NEEDLES, SPATULAS AND NON-INVASIVE DEVICES FOR OBTAINING AND TESTING BIOLOGICAL SAMPLES, NAMELY, FORCEPS; DIAPHRAGMS FOR CONTRACEPTION, COILS FOR CONTRACEPTION, NAMELY, INTRA-UTERINE DEVICES; PROTECTIVE SHEATHS FOR CONTRACEPTION, NAMELY, CONDOMSACTIVE—
042SCIENTIFIC RESEARCH AND DEVELOPMENTACTIVE—
044PROVISION OF INFORMATION RELATING TO HEALTH, WELL-BEING, NURSING, MEDICINE AND HEALTHCARE, PROVISION OF INFORMATION RELATING TO HEALTH, WELL-BEING, NURSING, MEDICINE AND HEALTHCARE VIA THE INTERNET, HEALTHCARE SERVICES; MEDICAL ASSISTANCE CONSULTANCY PROVIDED BY DOCTORS; MEDICAL CLINICS; MIDWIFE SERVICES; NURSING; PROFESSIONAL CONSULTANCY IN THE FIELD OF HEALTH, WELL-BEING, NURSING, MEDICINE AND HEALTHCAREACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB2): The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.

DateCodeEventWhat it means
Jan 21, 2009MAB2ABANDONMENT NOTICE MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Jan 21, 2009ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Jun 4, 2008CNSIINQUIRY AS TO SUSPENSION MAILED—
Jun 4, 2008CNSISUSPENSION INQUIRY WRITTEN—
Dec 4, 2007RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Jun 4, 2007RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Dec 4, 2006CNSLLETTER OF SUSPENSION MAILED—
Dec 4, 2006CNSLSUSPENSION LETTER WRITTEN—
Dec 4, 2006ACECAMENDMENT FROM APPLICANT ENTERED—
Dec 4, 2006CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 30, 2006ALIEASSIGNED TO LIE—
Nov 6, 2006MAILPAPER RECEIVED—
May 15, 2006CNSIINQUIRY AS TO SUSPENSION MAILED—
May 15, 2006CNSISUSPENSION INQUIRY WRITTEN—
Nov 10, 2005CNSLLETTER OF SUSPENSION MAILED—
Nov 10, 2005CNSLSUSPENSION LETTER WRITTEN—
Oct 21, 2005ACECAMENDMENT FROM APPLICANT ENTERED—
Oct 5, 2005CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 5, 2005MAILPAPER RECEIVED—
Apr 5, 2005CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 5, 2005CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 15, 2005ACECAMENDMENT FROM APPLICANT ENTERED—
Mar 1, 2005CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 1, 2005MAILPAPER RECEIVED—
Nov 24, 2004CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 23, 2004CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 23, 2004DOCKASSIGNED TO EXAMINER—
May 13, 2004NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance